Publications by authors named "K M Coy"
Vaccination Coverage by Age 24 Months Among Children Born During 2017-2021 - U.S.-Affiliated Pacific Islands.
MMWR Morb Mortal Wkly Rep
September 2024
Article Synopsis
- Childhood vaccination significantly contributes to public health by boosting life expectancy, lowering healthcare costs, and minimizing preventable diseases.
- Data from U.S.-affiliated Pacific Islands shows mixed success in meeting vaccination goals of 90% coverage by age 24 months, with substantial variability among different regions.
- As of June 2024, there has been an overall increase in vaccination coverage across jurisdictions, highlighting the need for targeted efforts to address delays and improve vaccination strategies in specific areas.
Article Synopsis
- * HPV vaccination was introduced in the U.S.-affiliated Pacific Islands (USAPI) from 2007-2016, mainly through school programs, and recent data (2013-2023) shows varying vaccination initiation rates among adolescent girls, from 58% in Palau to 97% in the Northern Mariana Islands.
- * As of December 2023, the Northern Mariana Islands exceeds the WHO's 90% vaccination goal, while American Samoa is on track; analyzing
The eight U.S. territories and freely associated states (TFAS) have historically faced unique social and structural barriers in the implementation of vaccination programs due to geographic remoteness, a high prevalence of socioeconomic disparities, increasing prevalence of natural disasters, limited vaccine providers and clinics, difficulties with procurement and shipping, and difficulty tracking highly mobile populations.
View Article and Find Full Text PDFBackground: Adults who are hesitant toward routinely recommended vaccines for adults may also be hesitant toward COVID-19 vaccines. However, the distribution and differences in hesitancy between routinely recommended vaccines and COVID-19 vaccines, and the association of hesitancy regarding routinely recommended vaccines and hesitancy with COVID-19 vaccination status and intent, is unknown.
Methods: Using the Research and Development Survey (RANDS) during COVID-19, Round 3, a probability-sampled, nationally representative, web and phone survey fielded from May 17 - June 30, 2021 (n = 5,434), we examined the distribution and difference in prevalence of hesitancy towards COVID-19 and vaccines in general, beliefs associated with vaccine hesitancy, and factors impacting plans to be vaccinated against COVID-19.
Pleomorphic xanthoastrocytoma (PXA) is a rare subset of primary pediatric glioma with 70% 5-year disease free survival. However, up to 20% of cases present with local recurrence and malignant transformation into more aggressive type anaplastic PXA (AXPA) or glioblastoma. The understanding of disease etiology and mechanisms driving PXA and APXA are limited, and there is no standard of care.
View Article and Find Full Text PDF